Cohen & Steers (CNS) director reports 436-share RSU-based stock award
Rhea-AI Filing Summary
Cohen & Steers, Inc. reported an equity grant to one of its directors. On 01/02/2026, the director acquired 436 shares of common stock at a price of $0, increasing their holdings to 23,591 shares held directly.
The filing explains that these 436 shares reflect common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the related shares are scheduled to be delivered to the director on the third anniversary of the grant date. This is a routine insider compensation transaction rather than an open-market stock purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 436 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Cohen & Steers (CNS) disclose in this Form 4?
The company disclosed that a director acquired 436 shares of Cohen & Steers common stock on 01/02/2026, reported as an acquisition at a price of $0.
Is the reported Cohen & Steers (CNS) transaction an open-market purchase?
No. The 436 shares were acquired at $0 as part of an equity compensation grant of restricted stock units, rather than an open-market purchase.
What role does the reporting person have at Cohen & Steers (CNS)?
The reporting person is identified as a director of Cohen & Steers, Inc., and the Form 4 is filed as a single reporting person.